First-Line Chemo for Small-Cell Lung Cancer is Not Superior to Second-Line
This is a discussion on First-Line Chemo for Small-Cell Lung Cancer is Not Superior to Second-Line within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; A meta-analysis has found that platinum-based regimens do not offer significant benefit in survival or overall tumor response, ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
10-08-2008, 09:21 AM
|
|||
|
|||
First-Line Chemo for Small-Cell Lung Cancer is Not Superior to Second-Line
A meta-analysis has found that platinum-based regimens do not offer significant benefit in survival or overall tumor response, compared with second-line nonplatinum-based regimens.
Medscape Medical News More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Beta Blockers Not Best First-Line Therapy for Hypertension: Meta-Analysis | industry_news | Other Clinical Pharmacy News | 0 | 09-22-2008 02:08 PM |
| Gefitinib for First-Line Therapy in Certain Asian Lung Cancer Patients | industry_news | Other Clinical Pharmacy News | 0 | 09-15-2008 06:19 PM |
| Initial Chemo Beneficial in Lung Cancer Brain Metastasis | industry_news | Other Clinical Pharmacy News | 0 | 08-07-2008 02:21 PM |
| Investigational Drug Combination Plus Chemotherapy Promising in Breast Cancer Cell Lines | industry_news | Other Clinical Pharmacy News | 0 | 07-03-2008 10:13 AM |
| Avastin, Erbitux battle for lung cancer market | industry_news | Biotechnology News | 0 | 04-22-2008 10:52 AM |
© 2008 DrugManagementForum™ powered by |
 |